BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Oglivy4D

We are excited about this change and hope that you will be tooThis rename in part reflects our new approach to developing medical education programmes specifically designed to change behaviour. Intrigued? To find out more please contact us by email ogilvy4d@ogilvy4d.com or by phone +44 (0)1865 320 200
The new Ogilvy4D website www.ogilvy4d.com is under development – please check back soon and bookmark this page to keep up-to-date with our latest news


Contact Details:
Minns Business Park,Godstow Court 5,west way
OXFORD
Oxfordshire
United Kingdom
Tel:44 (0)1865 320 200
Fax:44(0) 865 320 201
Email:ogilvy4d@ogilvy4d.com
WWW:

www.4dcommunications.com/




Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 240 times since April 2007, the link to the organisation's website has been followed 46 times

Recent Search Terms used to find this page: @ogilvy4d email | oglivy4d | ogilvy4d | Oglivy4D | oglivy4D | Oglivy4D | oglivy4D | .

Search for more companies in OXFORD

Search for more companies in Oxfordshire



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Oglivy4D
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.